Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma
- 2 August 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Virchows Archiv
- Vol. 447 (4), 695-700
- https://doi.org/10.1007/s00428-005-0003-6
Abstract
Androgens and androgen receptors (AR) are involved in the pathogenesis of breast cancer. Epidemiological studies have shown a significant association between the risk of breast cancer and androgens. However, the functional role and clinical value of AR expression in breast carcinoma have still not been clearly defined. The present study was set up to investigate the prevalence of ARs in a series of consecutive invasive breast carcinomas (IBCs) and to evaluate the patterns of AR phenotypes in a series of selected invasive lobular carcinomas (ILCs). Among the 250 consecutive IBCs (consisting of 212 ductal and 38 lobular neoplasms), AR immunoreactivity was observed in 151/250 (60.4%) cases, being expressed in 118/212 (56%) ductal and 33/38 (87%) lobular carcinomas (a statistically significant difference, χ2=11.82). AR expression was frequently associated with ER (65.2%, χ2=14.33) and PR positivity (66.9%, χ2=7.36). Most AR positive cases showed a low proliferative index (63.7%) and a low or intermediate histological grade (G1–G2, 63.9%). Among the 80 selected ILCs, AR expression was observed in 64/80 (80%) cases. Our results confirm that ARs are expressed in most breast cancers. Moreover, we demonstrated that AR positivity is particularly marked in lobular neoplasms. In addition, AR positive carcinomas are frequently characterized by a low or intermediate grade, a low proliferative index and ER and/or PR co-expression.Keywords
This publication has 41 references indexed in Scilit:
- Endogenous sex hormones and subsequent breast cancer in premenopausal womenInternational Journal of Cancer, 2004
- Androgen Receptor Expression in Estrogen Receptor–Negative Breast CancerAmerican Journal of Clinical Pathology, 2003
- Androgen receptor status in female breast cancer: RT-PCR and Western blot studiesZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast CancerAnnals of Internal Medicine, 1999
- Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factorsThe Journal of Pathology, 1993
- Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues.Journal of Histochemistry & Cytochemistry, 1993
- Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancerInternational Journal of Cancer, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Estrogen and Progesterone Receptor Determinations in Breast Cancer—Technology, Biology and Clinical SignificanceActa Oncologica, 1988
- Oestrogen receptors and breast cancer: Current statusBritish Journal of Surgery, 1980